Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Ingevity Corporation
- Innospec Inc.
累计表现对比（基数100）
每项资产在2025年10月13日时基数为100；数值120表示自该日起上涨20%（最近共同日期：2026年10月9日）。
指标
“不适用”表示该指标对此类资产没有意义：不应进行比较。
| 指标 | Ingevity CorporationStock | Innospec Inc.Stock |
|---|---|---|
| 业绩与风险 | ||
| Performance over the periodChange in price between the first and last common dates. | +30.2% | +28.4% |
| Annualized performanceAverage annual return that would produce the same total performance. | +30.6% | +28.7% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 35.8% | 23.5% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −19.2% | −25.5% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | 0.95 | 1.15 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −3.3% | −2.1% |
| 基本面 | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 2.4B $ | 2.36B $ |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 99.7 | 19.5 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 2.1 | 1.3 |
| Net marginShare of revenue retained as profit. | 4.7% | 6.6% |
| Return on equityReturn on equity (ROE). | 30.1% | 9.1% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | −5.2% | +11.8% |
| Dividend yieldAnnual dividend relative to the share price. | None | 1.83% |
| Debt / equityFinancial debt relative to shareholders' equity. | 2,636% | 4% |
期间相关性
取值范围为−1至1：接近1时，两类资产同涨同跌；接近0时，二者走势相互独立。
- Ingevity Corporation / Innospec Inc.0.54
对比分析
由人工智能生成的分析AI 仅根据上述数据比较所选资产，并指出哪些指标不可比。只有在您请求时才会生成文字内容。
以上信息仅供教育参考，不构成投资建议或个性化推荐。过往业绩不预示未来表现。